$0.9711
-0.01-1.05%
At close: -
$0.9900
0.021.95%
After Hours: Mar 21, 4:00 PM EDT
Comments
Loading...
Artelo Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:ARTL | Benzinga
Artelo Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 3
EPS
$-1.170
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Artelo Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARTL | Artelo Biosciences | -$0.78 | — | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| ARTL | Artelo Biosciences | -$0.99 | -$0.38 | -$1.17 | -207.89% | $0.00 | — | $0.00 | — | 03/03/2025 | Get Alert |
| ARTL | Artelo Biosciences | -$0.83 | -$0.46 | -$0.35 | 23.91% | $0.00 | — | $0.00 | — | 11/12/2024 | Get Alert |
| ARTL | Artelo Biosciences | -$0.56 | -$0.85 | -$0.75 | 11.76% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
| ARTL | Artelo Biosciences | -$0.76 | -$1.05 | -$0.78 | 25.71% | $0.00 | — | $0.00 | — | 05/13/2024 | Get Alert |
| ARTL | Artelo Biosciences | -$1.18 | -$0.56 | -$0.99 | -76.79% | $0.00 | — | $0.00 | — | 03/25/2024 | Get Alert |
| ARTL | Artelo Biosciences | -$0.87 | -$0.65 | -$0.83 | -27.69% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| ARTL | Artelo Biosciences | -$0.75 | -$0.81 | -$0.56 | 30.86% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| ARTL | Artelo Biosciences | -$0.70 | -$0.93 | -$0.76 | 18.28% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| ARTL | Artelo Biosciences | -$1.05 | -$0.73 | -$1.18 | -61.64% | $0.00 | — | $0.00 | — | 03/31/2023 | Get Alert |
| ARTL | Artelo Biosciences | -$1.37 | -$0.91 | -$0.82 | 9.89% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| ARTL | Artelo Biosciences | -$1.65 | -$0.85 | -$0.87 | -2.35% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| ARTL | Artelo Biosciences | -$2.10 | -$1.05 | -$0.75 | 28.57% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| ARTL | Artelo Biosciences | -$2.10 | -$0.75 | -$1.20 | -60.00% | $0.00 | — | $0.00 | — | 01/11/2022 | Get Alert |
| ARTL | Artelo Biosciences | -$2.85 | — | -$1.05 | — | $0.00 | — | $0.00 | — | 11/29/2021 | Get Alert |
| ARTL | Artelo Biosciences | -$4.05 | -$1.35 | -$1.50 | -11.11% | $0.00 | — | $0.00 | — | 07/12/2021 | Get Alert |
| ARTL | Artelo Biosciences | -$6.00 | -$1.50 | -$1.65 | -10.00% | $0.00 | — | $0.00 | — | 04/13/2021 | Get Alert |
| ARTL | Artelo Biosciences | -$6.00 | -$5.70 | -$2.10 | 63.16% | $0.00 | — | $0.00 | — | 01/13/2021 | Get Alert |
| ARTL | Artelo Biosciences | -$6.30 | — | -$2.85 | — | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| ARTL | Artelo Biosciences | -$6.00 | — | -$4.05 | — | $0.00 | — | $0.00 | — | 07/13/2020 | Get Alert |
| ARTL | Artelo Biosciences | — | — | -$6.00 | — | — | — | $0.00 | — | 04/14/2020 | Get Alert |
Artelo Biosciences (ARTL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-1.17 | $-0.38 | -207.9 % |
| Q3 | 2024-11-12 | $-0.35 | $-0.46 | 23.9 % |
| Q2 | 2024-08-13 | $-0.75 | $-0.85 | 11.8 % |
| Q1 | 2024-05-13 | $-0.78 | $-1.05 | 25.7 % |
Artelo Biosciences (ARTL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?
Artelo Biosciences (ARTL) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Artelo Biosciences (NASDAQ:ARTL)?
The Actual EPS was $-1.17, which missed the estimate of $-0.38.
What were Artelo Biosciences’s (NASDAQ:ARTL) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.